Hao Shi, PhD ’20, is founder of a Series A startup, Kanvas makes cancer therapy more effective, by improving the gut microbiome, we talked about:
- the importance of the gut microbiome, the effectiveness of cancer immunotherapy
- scaling up the startup, from 2 cofounders to 30 employees, with clinical trials on the way
- his personal journey from starting his PhD at Cornell and commercializing his research
(00:00) What is the gut microbiome, and what is cancer immunotherapy (05:00) Gut microbiome is dynamic, important to have a stable therapeutic (07:50) How the pill affects the gut microbiome (10:00) Importance of the imaging platform (13:07) First clinical trial (18:56) Commercializing his PhD research (22:18) How he chose his PhD thesis (27:02) Growing the startup team (33:00) Closing question